Here's Wouldn't Touch Moderna: Why I Won't Bet on Its Next Growth Engine
Moderna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
Indices rise and fall as growth, inflation, and risk appetite shift; news and expectations reshape valuation baselines and asset flows.
21,301 articlesModerna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
Wolfspeed has bounced on recent news, but deep profitability and liquidity issues linger. This guide breaks down the ...
A bold move by Berkshire Hathaway’s new leadership shifted power in the tech landscape. This is how Greg Abel built b...
CrowdStrike faced a sharp sell-off for a second consecutive day after a sector-wide reaction to new AI security produ...
A Brazilian fund made a sizable bet on MercadoLibre even as the stock slid over the past year. This article unpacks t...
The auto industry is changing fast, and big, cash-rich automakers may be overlooked. This guide explains why investor...
Even with perfect foreknowledge, timing the market rarely beats a steady, long-term plan. This article breaks down wh...
Nuclear energy is back on the radar as a reliable, scalable power source. This guide explains how a $5,000 investment...
ASML delivered a powerhouse quarter that suggests AI infrastructure spending remains resilient. With Intel set to rep...
When a member of the texas capital bancshares board makes a sizable purchase, it often prompts questions from investo...
A prominent fund has poured roughly $55 million into Dianthus as the stock climbs 350%. This article breaks down what...
Four years after their fight, questions about how money flows in celebrity deals continue to surface. This guide unpa...